Skip to content
Home/Companies/Healthcare/Nordic Biomarker

Nordic Biomarker

Healthcare·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Nordic Biomarker?

Nordic Biomarker is currently owned by Procuritas Capital Investors through PCI VII (2022 vintage), since 2022.

Hand-verified · updated 2026-08-17

Procuritas Capital Investors
Investor
Procuritas Capital Investors
PCI VII · 2022 · Small-Mid Buyout

Key facts

HQSweden
SectorHealthcare
StatusActive

More from PCI VII

Other portfolio companies in the same fund.

Parkman
Active
Business ServicesSweden· 2025
Energima
Active
Business ServicesNorway· 2024
Precision BioLogic
Active
HealthcareCanada· 2024
PropTech
Active
Real EstateSweden· 2023
Werksta
Active
Business ServicesSweden· 2022
weselect
Active
HR TechSweden· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Nordic Biomarker

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Nordic Biomarker?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Nordic Biomarker.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue